Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Grosicki, Sebastian; ...; Bila, Jelena S; ...; (broj, koautora 58)

Results

eNauka > Results > Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

Title:	Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial
Authors:	Grosicki, Sebastian; ...; Bila, Jelena S ; ...; (broj, koautora 58)
Issue Date:	2020
Publication:	LANCET
ISSN:	0140-6736 Lancet Search Idenfier
Type:	Article
Collation:	vol. 396 br. 10262 str. 1563-1573
WoS-ID:	000588778800028
URI:	https://enauka.gov.rs/handle/123456789/797056
Project:	Karyopharm Therapeutics
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	21aM21a

169
WEB OF SCIENCE^TM

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.